Once-daily tigecycline for outpatient parenteral antibiotic therapy: a single-centre observational study

BACKGROUND: Tigecycline has potential utility in the treatment of complex polymicrobial infections or those caused by MDR organisms in the ambulatory care setting owing to its breadth of antimicrobial coverage. Whilst licensed for twice-daily IV administration, its long half-life permits once-daily...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Stephen, Chin, Hui Yin, Heard, Katie L, Kamranpour, Pegah, Bartholomew, Brent, Mughal, Nabeela, Moore, Luke S P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210309/
https://www.ncbi.nlm.nih.gov/pubmed/34222958
http://dx.doi.org/10.1093/jacamr/dlz085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210309/
https://www.ncbi.nlm.nih.gov/pubmed/34222958
http://dx.doi.org/10.1093/jacamr/dlz085

Ejemplares similares